News May 2016: GlycoSeLect Announces Investment & Development Partnership with KBI Biopharma More >>
GlycoSeLect Ltd Completes 450K Seed Funding Round
News Jan 2017: Silicon Republic - Innovation: GlycoSeLect Listed as One of "10 Marvellous Medtec Start-Ups You Need to Know" More >>
KBI BioPharma Inc. and Enterprise Ireland Invest in Irish Biotechnology Separations Company, GlycoSeLect Ltd., to Complete its Seed Funding Round
Latest News: October 24th 2017
RPLs are enhanced glycoselective bioaffinity proteins that enable efficient detection, analysis and selective isolation of glycosylated biomolecules. Applications
GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
Recombinant Prokaryotic Lectins